HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Akli, S. Articles by Poenaru, L. Search for Related Content PubMed PubMed Citation Articles by Akli, S. Articles by Poenaru, L. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 265, Issue 13, 7324-7330, May, 1990

A "G" to "A" mutation at position -1 of a 5' splice site in a late infantile form of Tay-Sachs disease

S Akli, J Chelly, C Mezard, S Gandy, A Kahn and L Poenaru
Unite de Recherches en Genetique et Pathologie Moleculaires, Institut National de la Sante et de la Recherche Medicale, U129, Paris, France.

Tay-Sachs disease is an autosomal recessive genetic disease caused by a deficiency in beta-hexosaminidase A. We have characterized a new mutation in a Tunisian patient displaying a late infantile form of Tay- Sachs disease. Northern blot analysis of patient's fibroblast total RNAs shows a broad, fast migrating band in the region of the normal beta-hexosaminidase alpha transcripts. The mRNA coding for beta- hexosaminidase alpha subunit was first reverse transcribed and then amplified in four overlapping segments spanning the entire coding sequence by polymerase chain reaction. We found in the products of polymerase chain reaction (PCR) that amplify the segment spanning exons 2-7, in addition to a normal fragment, two smaller size fragments, one of which is also seen in normal control fibroblasts. The analysis of the patient's specific abnormal fragment by hybridization with exon- specific oligonucleotides and then sequencing allowed us to conclude that this fragment lacked exon 5. The other smaller species lacked exons 4 and 5 in both patient and normal control. The sequence of a genomic fragment containing exon 5 and of the patient's normal cDNA fragment spanning exons 2-7, revealed a point mutation G to A at the last nucleotide of exon 5. This mutation doesn't change the sense of the affected codon. Northern blot of patient's fibroblast poly(A+) RNAs allowed us to quantify two of the forms of transcripts seen by PCR. In the patient, the normal size transcript and the exon 5-deleted transcript represent, respectively, 3 and 7% of the normal control beta- hexosaminidase alpha mRNA. We propose that this point mutation is responsible for an inefficient and abnormal processing of the mutant transcript resulting in the appearance of two low abundance spliced mRNAs. One is lacking exon 5 and most likely codes for an inactive protein; the other is similar to normal beta-hexosaminidase alpha mRNA, except for the presence of the silent G to A mutation and codes therefore for a normal enzyme accounting for the 2.5% residual beta- hexosaminidase A activity measured in patient's fibroblasts by a fluorometric assay. The third form, without exons 4 and 5, is also evidenced in normal fibroblasts by PCR so that we think that it is not related to Tay-Sachs disease.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				F. Pagani, M. Raponi, and F. E. Baralle Synonymous mutations in CFTR exon 12 affect splicing and are not neutral in evolution PNAS, May 3, 2005; 102(18): 6368 - 6372. [Abstract] [Full Text] [PDF]

				A Todorova, B Halliger-Keller, M C Walter, M-C Dabauvalle, H Lochmuller, and C R Muller A synonymous codon change in the LMNA gene alters mRNA splicing and causes limb girdle muscular dystrophy type 1B J. Med. Genet., October 1, 2003; 40(10): e115 - 115. [Full Text] [PDF]

				J C Sanchez-Gutierrez, T Benlloch, M A Leal, B Samper, I Garcia-Ripoll, and J E Feliu Molecular analysis of the aldolase B gene in patients with hereditary fructose intolerance from Spain J. Med. Genet., September 1, 2002; 39(9): e56 - 56. [Full Text] [PDF]

				A. Murray, C. Donger, C. Fenske, I. Spillman, P. Richard, Y. B. Dong, N. Neyroud, P. Chevalier, I. Denjoy, N. Carter, et al. Splicing Mutations in KCNQ1 : A Mutation Hot Spot at Codon 344 That Produces In Frame Transcripts Circulation, September 7, 1999; 100(10): 1077 - 1084. [Abstract] [Full Text] [PDF]

				C. Leroy-Matheron, M. Gouault-Heilmann, M. Aiach, and S. Gandrille A Mutation of the Active Protein S Gene Leading to an EGF1-Lacking Protein in a Family With Qualitative (Type II) Deficiency Blood, June 15, 1998; 91(12): 4608 - 4615. [Abstract] [Full Text] [PDF]

				W. Chen, S. Kubota, and Y. Seyama Alternative pre-mRNA splicing of the sterol 27-hydroxylase gene (CYP 27) caused by a G to A mutation at the last nucleotide of exon 6 in a patient with cerebrotendinous xanthomatosis (CTX) J. Lipid Res., March 1, 1998; 39(3): 509 - 517. [Abstract] [Full Text]

				P. R Jarman, O Bandmann, C D Marsden, and N W Wood GTP cyclohydrolase I mutations in patients with dystonia responsive to anticholinergic drugs J. Neurol. Neurosurg. Psychiatry, September 1, 1997; 63(3): 304 - 308. [Abstract] [Full Text] [PDF]

				H. Kanno, H. Fujii, D. C. Wei, L.C. Chan, A. Hirono, I. Tsukimoto, and S. Miwa Frame Shift Mutation, Exon Skipping, and a Two-Codon Deletion Caused by Splice Site Mutations Account for Pyruvate Kinase Deficiency Blood, June 1, 1997; 89(11): 4213 - 4218. [Abstract] [Full Text] [PDF]